Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension.
CorWave is a medical device company developing innovative heart pumps.
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.
Werewool develops a fiber development platform to create biodegradable fibers.
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.
Capturing the human-bacterial relationship to address the seemingly impossible question - will this drug work [for me?]
Nuage Therapeutics engages in developing drugs which target proteins in disordered regions for challenging indications faced by patients.
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.
Mablink Bioscience is a biotechnology company.
Inspirna is a biotechnology company developing drugs for the treatment of cancer.
DMC Biotechnologies produces bio-based chemicals using fermentation.
Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.
Home Biosciences is a European venture builder dedicated to biotech.
Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).
Sphere Bio specializes in tools for single cell analysis and isolation, facilitating discovery in the biotech field.
Protera is a biotechnology company that produce protein-based food ingredients.
Mnemo Therapeutics specializes in biotechnology and life science.
Pyrowave closes the loop of polymer lifecycle by bringing plastic waste back to life.
Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.
NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases.
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
Sofinnova Partners has invested in 148 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sofinnova Partners's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Medical, Medical Device. The firm invests across 26 different industry categories.
Among tracked funding rounds, Amolyt Pharma received $138.6M in a Series C round. Sofinnova Partners's total known invested capital is $6.3B.
Sofinnova Partners's average investment size is $48.1M across its portfolio of 148 companies.
Recent Sofinnova Partners portfolio additions include Sitryx Therapeutics, Gradient Denervation Technologies, Corwave, Mozart Therapeutics, TISSIUM. These companies were founded in 2020 or later.